Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome

被引:79
作者
Park, J. H.
Rhee, P-L.
Kim, G.
Lee, J. H.
Kim, Y-H.
Kim, J. J.
Rhee, J. C.
Song, S. Y.
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Gastroenterol, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea
关键词
enteroendocrine cell; irritable bowel syndrome; visceral hypersensitivity;
D O I
10.1111/j.1365-2982.2006.00771.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The objective of this study was to determine whether or not the number of enteroendocrine cells (ECs) in the gut is related to visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome (D-IBS). Twenty-five subjects with D-IBS (mean, 43.1 years; 16 women, nine men) were recruited into our study, along with 13 healthy controls (mean, 40.7 years; nine women, four men). Maximally tolerable pressures were evaluated via barostat testing, and the levels of ECs were immunohistochemically identified and quantified via image analysis. The numbers of ECs between the D-IBS subjects and the controls were not significantly different in the terminal ileum, ascending colon and rectum. However, the maximally tolerable pressures determined in the D-IBS subjects were significantly lower than those of the control subjects (P < 0.01), and we detected a significant relationship between the maximally tolerable pressures and the numbers of ECs in the rectum (r = -0.37, P < 0.01). Rectal sensitivity was enhanced to a greater degree in D-IBS patients exhibiting an elevated level of rectal ECs. This study provides some evidence to suggest that ECs play an important role in visceral hypersensitivity.
引用
收藏
页码:539 / 546
页数:8
相关论文
共 38 条
[1]  
*AM GASTR ASS, 2002, GASTROENTEROLOGY, V123, P2105, DOI DOI 10.1053/GAST.2002.37095B
[2]  
Baig M. K., 2002, Colorectal Dis, V4, P348, DOI 10.1046/j.1463-1318.2002.00404.x
[3]   Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study [J].
Bearcroft, CP ;
Perrett, D ;
Farthing, MJG .
GUT, 1998, 42 (01) :42-46
[4]  
Beck AT, 1961, ARCH GEN PSYCHIAT, V4, P53, DOI DOI 10.1001/ARCHPSYC.1961.01710120031004
[5]   Rectal distention testing in patients with irritable bowel syndrome:: Sensitivity, specificity, and predictive values of pain sensory thresholds [J].
Bouin, M ;
Plourde, V ;
Boivin, M ;
Riberdy, M ;
Lupien, F ;
Laganière, M ;
Verrier, P ;
Poitras, P .
GASTROENTEROLOGY, 2002, 122 (07) :1771-1777
[6]   Endogenous adenosine differentially modulates 5-hydroxytryptamine release from a human enterochromaffin cell model [J].
Christofi, FL ;
Kim, M ;
Wunderlich, JE ;
Xue, JJ ;
Suntres, Z ;
Cardounel, A ;
Javed, NH ;
Yu, JG ;
Grants, I ;
Cooke, HJ .
GASTROENTEROLOGY, 2004, 127 (01) :188-202
[7]   Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome [J].
Coates, MD ;
Mahoney, CR ;
Linden, DR ;
Sampson, JE ;
Chen, J ;
Blaszyk, H ;
Crowell, MD ;
Sharkey, KA ;
Gershon, MD ;
Mawe, GM ;
Moses, PL .
GASTROENTEROLOGY, 2004, 126 (07) :1657-1664
[8]   Role of serotonin in the pathophysiology of the irritable bowel syndrome [J].
Crowell, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (08) :1285-1293
[9]   Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS [J].
Dunlop, SP ;
Jenkins, D ;
Neal, KR ;
Spiller, RC .
GASTROENTEROLOGY, 2003, 125 (06) :1651-1659
[10]  
El-Salhy M, 1999, SCAND J GASTROENTERO, V34, P1007